Last: | $ |
---|---|
Change Percent: | 0.19% |
Open: | $5.25 |
Close: | $5.24 |
High: | $5.44 |
Low: | $4.97 |
Volume: | 34,403 |
Last Trade Date Time: | 06/07/2019 04:56:26 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $5.25 | $5.24 | $5.44 | $4.97 | 34,403 | 06-07-2019 |
$ | $5.29 | $5.23 | $5.29 | $5.0101 | 11,059 | 06-06-2019 |
$ | $5.66 | $5.11 | $5.66 | $5.04 | 26,702 | 06-05-2019 |
$ | $5.21 | $5.50 | $5.55 | $5.18 | 32,550 | 06-04-2019 |
$ | $4.98 | $5.31 | $5.6294 | $4.93 | 92,052 | 06-03-2019 |
$ | $4.91 | $4.93 | $5.04 | $4.90 | 19,776 | 05-31-2019 |
$ | $5.10 | $4.98 | $5.10 | $4.86 | 19,645 | 05-30-2019 |
$ | $4.91 | $4.95 | $5.00 | $4.88 | 15,540 | 05-29-2019 |
$ | $4.98 | $4.91 | $4.98 | $4.76 | 3,849 | 05-28-2019 |
$ | $4.7775 | $4.96 | $4.98 | $4.7775 | 7,398 | 05-27-2019 |
$ | $4.7775 | $4.96 | $4.98 | $4.7775 | 7,398 | 05-24-2019 |
$ | $4.98 | $4.83 | $4.98 | $4.8076 | 6,506 | 05-23-2019 |
$ | $4.99 | $4.98 | $5.0022 | $4.7692 | 18,838 | 05-22-2019 |
$ | $5.06 | $4.98 | $5.095 | $4.87 | 9,007 | 05-21-2019 |
$ | $4.87 | $4.92 | $5.14 | $4.71 | 56,572 | 05-20-2019 |
$ | $5.0109 | $5.07 | $5.07 | $4.99 | 6,050 | 05-17-2019 |
$ | $5.38 | $5.07 | $5.426 | $4.90 | 43,683 | 05-16-2019 |
$ | $5.08 | $5.20 | $5.21 | $4.85 | 25,553 | 05-15-2019 |
$ | $5.03 | $5.07 | $5.14 | $5.00 | 17,207 | 05-14-2019 |
$ | $5.29 | $4.99 | $5.355 | $4.90 | 41,598 | 05-13-2019 |
News, Short Squeeze, Breakout and More Instantly...
Rexahn Pharmaceuticals Inc. Company Name:
RNN Stock Symbol:
NYSE Market:
Rexahn Pharmaceuticals Inc. Website:
ROCKVILLE, Md., May 28, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced that it will voluntarily transfe...
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that are difficult to treat, today announced financial results for the first ...
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New Jersey- and Suzhou, China-based biopharmaceutical company, today announced ...